EcoDrugPlus

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSTTRG00000011145
Gene Symbol: ALOX5AP
1 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSTTRG00000001865
Gene Symbol: AVPR1A
1 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSTTRG00000007453
Gene Symbol: AVPR2
1 Cross references
231 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSTTRG00000006913
Gene Symbol: AHR
1 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSTTRG00000014869
Gene Symbol: AURKA
1 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSTTRG00000010318
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSTTRG00000004857
Gene Symbol: AURKC
1 Cross references
96 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSTTRG00000000978
Gene Symbol: BACE1
1 Cross references
217 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSTTRG00000003529
Gene Symbol: BDKRB2
1 Cross references
356 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSTTRG00000003809
Gene Symbol: BCHE
1 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSTTRG00000013820
Gene Symbol: CALCRL
1 Cross references
147 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSTTRG00000000232
Gene Symbol: CACNA2D1
1 Cross references
285 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).